Failure to recognise the threat of India's IP abuse is a major step back: Congressman Orrin Hatch.
Even as India continues on the priority watch list of the Office of the US Trade Representative, strong voices from Washington, DC, have spoken out in favour of India, reports Aziz Haniffa/Rediff.com.
Prez says that India has not assured the United States that it will provide 'equitable and reasonable access to its markets'.
The unilateral pressure by US administration on India, at the behest of US Business Associations lobby through US International Trade Commission investigations and request to USTR to enlist India under Priority Foreign Country under Special 301 review, lacks legitimacy under WTO framework, the signatories to the letter said.
While the Trump administration wants India to lower the trade barriers and embrace "fair and reciprocal" trade, India has raised tariffs on 28 items exported from the US in retaliation to America's withdrawal of preferential access for Indian products.
Led by Ajay Shriram, chairman and senior managing director, DCM Shriram, the CEO's delegation seeks to convey to their American counterparts the sense of optimism amongst Indian industry.
The US and India likely to sign a high quality bilateral investment treaty to create an enabling business environment.
With Donald Trump the appeal has to be to his business instincts in which his personal interests seem to play a significant role, says former foreign secretary Kanwal Sibal.
Adverse IPR report expected this week;Poor labelling could take fight to WTO
Manish Market and Lamington Road in Mumbai, and Chenoy Trade Center and Hong Kong Bazar in Hyderabad are the other four "notorious markets" identified by the US Trade Representatives in its report released on Wednesday.
The council resisted intense pressure from the powerful manufacturing, pharma and other trade lobbies that have urged the Obama administration to enact punitive measures against India for a laundry list of alleged intellectual property and patent violations.
Western drugmakers, including Pfizer Inc, Novartis AG, Roche Holding AG and Sanofi SA, covet a bigger share of the fast-growing Indian drugs market.
Equity benchmarks erased early gains after realty, capital goods, teck, auto, PSU, IT, power and bankex counters came under selling pressure, falling up to 1.28 per cent.
What did Narendra Modi tell former Utah governor Jon M Huntsman when he met him? Aziz Haniffa/Rediff.com reports from Washington, DC.
The Trump regime has informed the Congress that it 'strongly supports' transfers of F-18 and F-16 fighter proposals put forth by Boeing and Lockheed Martin respectively.
Fighting fake brand peddlers. How the complex web of counterfeit goods threatens to trip e-commerce giants in the country.
India and the US should not get into any lengthy investigations for business related concerns.
Incoming US President Donald Trump has assembled a core team that is -- not surprisingly -- overwhelmingly white and male.
Rahul Gandhi has taken the fight to the Modi government, feels Milan Vaishnav. Aziz Haniffa/Rediff.com reports from Washington, DC.
'It is in the interest of both sides that the visit of the US President is seen as being successful. Both sides have invested considerable political capital in it. This rapid exchange of visits and the decisions taken have to be justified, beyond the symbolism, which is no doubt important in itself. This opportunity to impart a fresh momentum to ties should not be missed,' says former foreign secretary Kanwal Sibal.
'India is no longer the India of the '70s and the '80s.' 'It's a large country with the fastest growing economy.' 'In working with India, you just can't go and humiliate the nation publicly.' USIBC President Mukesh Aghi tells Aziz Haniffa/Rediff.com about how he advises American companies to do business with India, what he thinks of Modi's government and the way forward for the India-US relationship.
